Legato Capital Management LLC Verona Pharma PLC Transaction History
Legato Capital Management LLC
- $718 Million
- Q4 2024
A detailed history of Legato Capital Management LLC transactions in Verona Pharma PLC stock. As of the latest transaction made, Legato Capital Management LLC holds 24,853 shares of VRNA stock, worth $1.66 Million. This represents 0.16% of its overall portfolio holdings.
Number of Shares
24,853
Previous 10,670
132.92%
Holding current value
$1.66 Million
Previous $306,000
277.12%
% of portfolio
0.16%
Previous 0.04%
Shares
4 transactions
Others Institutions Holding VRNA
# of Institutions
219Shares Held
70.5MCall Options Held
1.4MPut Options Held
299K-
Perceptive Advisors LLC New York, NY6.39MShares$427 Million9.9% of portfolio
-
Nea Management Company, LLC Timonium, MD5.58MShares$373 Million18.53% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.38MShares$226 Million9.42% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.13MShares$209 Million2.79% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx3.13MShares$209 Million2.81% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $4.07B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...